# Fosun Health Capital

> Fosun Health Capital is a VC fund in Xuhui backing Medical and Health Care. See 19 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Xuhui, China
- Total investments: 19
- Last investment: May 2026
- Lead investor: 58%
- Last updated: Aug 2026
- Website: http://www.fosunhealthcapital.com/

Fosun Health Capital is a VC fund in Xuhui focused on Medical and Health Care. Fujian Capital New Drug Innovation Fund is the first new drug innovation fund mainly based on the holding incubation model

## Contacts

5 contacts available for Fosun Health Capital. Shizune tracks 2 team members at Fosun Health Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/fosun-health-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 7 | 37% |
| Health Care | 5 | 26% |
| Biotechnology | 5 | 26% |
| Pharmaceutical | 4 | 21% |
| Biopharma | 3 | 16% |

17 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 26% |
| Series A | 4 | 21% |
| Angel | 3 | 16% |
| Series B | 3 | 16% |
| Series C | 3 | 16% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 14 | 74% |
| United States | 1 | 5% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Jin Bi | Executive General Manager | 1 | https://shizune.co/investors/profile/jin-bi |
| Li Fan | CEO | 1 | https://shizune.co/investors/profile/li-fan-a7a5 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| BrainThink Technology | BrainThink Technology is a high-tech enterprise specializing in the research and development of brain-computer interface (BCI) technology. | $10M | Angel | May 18, 2026 |  |
| Fosun Kite Biotechnology | Fosun Kite Biotechnology develops immune cell therapy products. Fosun Kite Biotechnology is a joint venture of Shanghai Fosun Pharmaceutical (Group) Co., Ltd, and U.S. Kite Pharma. | $84.2M | Series A | Oct 17, 2025 |  |
| InxMed | InxMed is a clinical-stage biotech company focusing on developing "Best-in-Disease Combination" medicines to bring novel treatment options for patients. Our innovations are inspired by patients and driven by an in-depth understanding of disease biology and pharmacology. InxMed is committed to building a translational platform equippedwith global-level top-notch know-how and efficient execution capabilities. | $34M | Series C | Aug 22, 2025 |  |
| Hengtai Bio | Hengtai Bio is a biotechnology company focused on pharmaceutical manufacturing, specializing in the research, development, and large-scale production of high-quality pharmaceutical products. |  | Angel | Aug 07, 2025 |  |
| Cellbri | Cellbri is a manufacturing company that produces and sells automated CGT industrial instruments for cell processing programs. |  | Series B | Mar 27, 2025 |  |
| Celregen Therapeutics | Celregen Therapeutics is a pharmaceutical business that focuses on the development of novel medications in the domains of cell therapy and regenerative medicine. | $13.8M | Angel | Mar 18, 2025 |  |
| Transcend Vivoscope | Transcend Vivoscope is a biotechnology company that specializes in providing advanced microscopy imaging products and solutions. |  | Series B | Feb 12, 2025 |  |
| Aiyi animal medicine | Aiyi Animal Medicine develops and produces veterinary biological products and veterinary chemical medications. | $13.7M | Series C | Jan 06, 2025 |  |
| Jishi Medical | Jishi Medical is a med-tech company that specializes in the research and development of eye diseases and overall solutions for ophthalmology diagnosis and treatment. |  | Seed | Nov 08, 2024 |  |
| Celregen Therapeutics | Celregen Therapeutics is a pharmaceutical business that focuses on the development of novel medications in the domains of cell therapy and regenerative medicine. |  | Seed | Sep 14, 2024 |  |

10 of 19 investments shown.

## Co-investors
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 2 deals together
- [Shanghai Creation Investment](https://shizune.co/investors/profile/shanghai-creation-investment-management-co-ltd) — VC Fund, 2 deals together
- [Alibaba Health Information Technology](https://shizune.co/investors/profile/alibaba-health-information-technology) — VC Fund, 1 deal together
- [Asia Green Fund](https://shizune.co/investors/profile/asia-green-fund) — VC Fund, 1 deal together
- [Boehringer Ingelheim Venture Fund](https://shizune.co/investors/profile/boehringer-ingelheim-venture-fund) — VC Fund, 1 deal together
- [Boyuan Capital](https://shizune.co/investors/profile/boyuan-capital-4fca) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Fosun Health Capital invest in?

Fosun Health Capital invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 19 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Fosun Health Capital?

Public channels for Fosun Health Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Fosun Health Capital?

The team at Fosun Health Capital includes Jin Bi (Executive General Manager) and Li Fan (CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co